Servier/LinkedIn
Aug 11, 2025, 22:32
33 Oncology R&D Projects, 8 Medicines, 1 Mission: Fighting Cancer – Servier
Servier shared a post on LinkedIn:
“At Servier, we have been committed to fighting cancer for many years. Oncology is a major therapeutic priority for us, accounting for close to 70% of our R&D investments.
We currently have a portfolio of 8 medicines available to healthcare professionals and patients. Our major investments in the cancer are demonstrated through our robust pipeline of 33 oncology R&D projects.
Learn more about Servier.”
More posts featuring Servier.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Sep 2, 2025, 22:37
Sep 2, 2025, 22:03
Sep 2, 2025, 20:50
Sep 2, 2025, 18:53
Sep 2, 2025, 16:54